Ekso Bionics Holdings, Richmond, California, announced that a new randomized comparative clinical trial is currently under way in Europe. The trial, The MOST Study (mobility improved after stroke when a robotic device was used in comparison to physical therapy), is being initialized by Farsin Hamzei, MD, MHBA, chief physician of the Department of Neurological Rehabilitation, Moritz Klinik, Bad Klosterlausnitz, Germany. The study is investigating the impact of gait training with the Ekso GT™ on functional independence of 80 patients with impaired gait due to stroke when compared to conventional physiotherapy alone.
Early observations from clinical use of the Ekso GT for the rehabilitation of stroke patients at Moritz Klinik led to the development of this study, which is scheduled to conclude mid-year 2017.
